HOME >> BIOLOGY >> NEWS
Using genetic research to treat inflammatory diseases Vienna centre of excellence in biomedicine harnesses basic research

for Dermatology), the Vienna University of Agriculture, Forestry and Renewable Natural Resources (Centre for Ultrastructure Research), well-known pharmaceutical companies (Baxter and the Novartis Research Institute), and dynamic start-up companies (Biomax Informatics, Nanosearch, Polymun Scientific and Technoclone). The joint projects receive financial support from the Austrian Governments Kplus programme, administered by the Technologie Impulse Gesellschaft (TIG), and Vienna City Council which has invested directly in BMT.

"Common structures not only permit the efficient use of research resources but also generate lively exchanges of ideas and expertise, said BMT managing director Gudrun Baumann. "The centres unique concept fills a much criticised gap in the Austrian research sector. Rapid technology transfers and patent protection ensure that research results quickly find their way into treatments for patients.

In terms of quality of their scientific output, the university institutes that have joined forces to conduct research through BMT are among the Austrian "top five institutions. "But that by itself does not cure any patient, noted BMT scientific director Professor Bernd R. Binder who heads the Institute of Vascular Biology and Thrombosis Research. "Only research aiming for applicable results can translate breakthroughs in basic research rapidly into effective therapies.

This approach is reflected in the role played by the participating starts-ups with academic origins. These include Munich based Biomax Informatics, the partner that contributes bioinformatics know-how an increasingly important factor in genetic research. Biomax CEO Dr. Klaus Heumann said: "The experience of the dynamic biotech environment in Vienna is invaluable to us. For instance, collaborating with BMTs working groups is helping us develop a new chip for therapies of inflammatory disease.

A similar view came from Prof. Hans Peter Schwarz, Vice President Sc
'"/>

Contact: Gudrun Baumann
gudrun.baumann@bmt-research.at
43-1-8673691
PR&D Public Relations for Research & Development
26-Nov-2001


Page: 1 2 3

Related biology news :

1. Using statistics to decipher secrets of natural mutation
2. Using science to restore habitat for declining species
3. Using soils as filters to prevent crypto from moving to the groundwater
4. Using a companion crop to control weeds organically
5. Using plants and microbes to purify polluted industrial wastewater
6. Using GPR to estimate tree root biomass
7. Using computational power tools to bolster systems biology
8. Using RNA interference to tune gene activity in stem cells
9. Using sewage sludge as fertilizer
10. Using the oceans living light shows to fight terrorism or track the planets most massive migration
11. Using brain activity to identify risk for disorders

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... August 14, 2019 , ... An upcoming episode ... in microbiome therapeutics are helping to promote normal immune function in order to ... will educate about the DECODE.DESIGN.CURE™ technology platform, which rapidly develops microbiome therapeutics in ...
(Date:8/14/2019)... ... , ... Gateway Genomics , a leading developer of direct-to-consumer genetic tests ... annual Inc. 500|5000 list of fastest growing private companies, in the first year ... and generating revenue by March 31, 2015. Ranking in the list is determined by ...
(Date:8/6/2019)... ... August 06, 2019 , ... ... modeling system that could have far-reaching implications for personalized medicine, especially when seeking ... (PLSR), is able to predict which stem cell donors and manipulation methods might ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... ... June 17, 2019 , ... IVERIC bio, ... an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) vector for ... dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 related retinal ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... distribution network with the appointment of Biofeedback Tech Ltd as its ... are an essential part of many therapeutic treatments and clinical assessment protocols to ...
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, the ... national leader in opioid treatment, announced today they are partnering to combat the ... recently deployed its virtual care platform at the Mayo Clinic to drive shared ...
(Date:6/6/2019)... ... 05, 2019 , ... WCCT Global, Inc ., a full-service early phase ... they will be receiving 3 awards at the 2019 CRO Leadership Awards, to be ... the categories of overall Quality and Compatibility (Access to desired markets, cultural fit, timely ...
Breaking Biology Technology:
Cached News: